A nasal spray for treatment-resistant depression has delivered strong clinical results and rekindled investor hopes.

Allergic rhinitis, often called hay fever, mimics cold symptoms but isn’t caused by a virus or bacteria. Non-allergic rhinitis, triggered by irritants like smoke, strong odours, or weather changes, ...

After being dismissed countless times by doctors, Mark Knoop came across a Facebook page he says saved his life after getting ...

Lupin launches Ipratropium Bromide Nasal Solution in the US market; eyes expanding complex generics pipeline to over 200 ...

A panelist discusses how a prospective study demonstrated that twice-daily use of a nasal spray significantly improved tear ...

Lupin introduces ipratropium bromide nasal solution, 0.03% & 0.06% in US markets: Our Bureau, Mumbai Friday, July 4, 2025, 17:30 Hrs [IST] Global pharma major Lupin Limited (Lupin ...

Scientists have developed a nasal "molecular shield" that disarms pollen, blocking allergic reactions fast without the use of ...

Probation officials said youths and staff members were hospitalized after a 'suspected overdose and possible exposure to an ...

Positive study results in Phase 2 lead to a green light for the companies’ combination and plans to move their nasal spray ...

BPL-003 showed “robust” efficacy data in treatment-resistant depression, according to analysts from Jefferies, who noted that ...

Vending machines throughout Denver have distributed more than 1,800 free boxes of the overdose reversal medication naloxone since they debuted in April.